David Schoenfeld, PhD, is affiliated with the Biostatistics Center at Massachusetts General Hospital and the Department of Public Health at Harvard Medical School. His publications from 2016 to 2022 focus on clinical research in child and adolescent psychiatry, major depressive disorder, and schizophrenia/schizoaffective disorders. His work includes studies on transcranial photobiomodulation for depression, cognitive effects of cannabis abstinence in youth, and comparative effectiveness of treatments for bipolar disorder. He has frequently collaborated with co-authors such as A. Eden Evins and Andrew A. Nierenberg.
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
